Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Glean Urodynamics System received FDA clearance in March/June of 2025. Clinical data demonstrated safety and feasibility for wireless, catheter-free ambulatory urodynamic monitoring. The system enables more accurate diagnosis by collecting real-world bladder function data during normal activities rather than artificial lab settings. Early use at Cleveland Clinic confirmed improved patient comfort and diagnostic accuracy compared to traditional methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bright Uro.